Bio Green Med Solution, Inc. Common Stock
Here’s whether Bio Green Med Solution, Inc. Common Stock (BGMS) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.
Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.85% over 10 days); 3-month momentum positive (+60.4%); rising volume confirms the move (2.98x 30d avg). Concerns: RSI 84 — overbought, elevated pullback risk. Currently 77.6% off its 52-week high. Score: +3/7.
BGMS is trading below its 200-day MA (—) — a key warning sign the longer-term trend is under pressure. With an RSI of 83.8, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. With ~9 months of trading history, the return since first available bar is -75.1%. The current 77.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.